Berlin - Delayed Quote EUR
Nicox SA (NXOA.BE)
0.2260
-0.0020
(-0.88%)
At close: June 6 at 7:33:02 PM GMT+2
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-23,125
-18,481
-5,392
Investing Cash Flow
--
132
-175
4,949
Financing Cash Flow
--
8,643
13,409
19,584
End Cash Position
--
27,650
41,970
47,195
Capital Expenditure
--
-42
-8
-20
Issuance of Capital Stock
--
218
91
--
Issuance of Debt
--
8,964
13,713
20,597
Repayment of Debt
--
-165
0
--
Repurchase of Capital Stock
--
--
--
-633
Free Cash Flow
--
-23,167
-18,489
-5,412
12/31/2020 - 9/18/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
IMR.BE AC Immune SA
1.7820
+18.80%
BT1.BE Bone Therapeutics SA
0.0018
0.00%
5CV.HA CureVac NV
3.8120
-0.78%
2LB.MU Iovance Biotherapeutics Inc
1.5644
0.00%
P0F.F Egetis Therapeutics AB (publ)
0.3285
-5.06%
ALINT.PA IntegraGen SA
0.5220
0.00%
AYJ.HA Valneva SE
2.7240
-1.23%
2LB.F Iovance Biotherapeutics, Inc.
1.5496
-4.11%
AB3A.MU Sarepta Therapeutics Inc
37.49
+6.66%